National Oxygen Share Price
Sector: Chemical Manufacturing
111.75 -2.25 (-1.97%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
111.75
Today’s High
113.95
52 Week Low
94.95
52 Week High
165.00
Key Metrics
- Market Cap (In Cr) 56.35
- Beta 0.21
- Div. Yield (%) 0
- P/B -
- TTM P/E -
- Sector P/E 17.89
- Open Price 111.75
- Prev Close 115.75
National Oxygen Analysis
Price Analysis
-
1 Week-6.21%
-
3 Months3.5%
-
6 Month-10.24%
-
YTD-14.77%
-
1 Year-18.28%
Risk Meter
- 44% Low risk
- 44% Moderate risk
- 44% Balanced Risk
- 44% High risk
- 44% Extreme risk
National Oxygen News
Jhansi hospital fire kills 10 newborns: Modi, Adityanath announce ex-gratia
1 min read . 16 Nov 2024Watching YouTube is not adequate to perform aesthetic and hair transplant: NMC
2 min read . 27 Sep 2022National Oxygen Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 40.58
- Selling/ General/ Admin Expenses Total
- 3.33
- Depreciation/ Amortization
- 3.22
- Other Operating Expenses Total
- 10.28
- Total Operating Expense
- 46.27
- Operating Income
- -5.69
- Net Income Before Taxes
- -7
- Net Income
- -7
- Diluted Normalized EPS
- -13.9
- Period
- 2025
- Total Assets
- 31.1
- Total Liabilities
- 39.11
- Total Equity
- -8.01
- Tangible Book Valueper Share Common Eq
- -15.91
- Period
- 2025
- Cashfrom Operating Activities
- -0.18
- Cashfrom Investing Activities
- -0.21
- Cashfrom Financing Activities
- 0.45
- Net Changein Cash
- 0.07
- Period
- 2024
- Total Revenue
- 45.26
- Selling/ General/ Admin Expenses Total
- 3.38
- Depreciation/ Amortization
- 3.33
- Other Operating Expenses Total
- 10.55
- Total Operating Expense
- 47.35
- Operating Income
- -2.09
- Net Income Before Taxes
- -3.23
- Net Income
- -3.23
- Diluted Normalized EPS
- -6.41
- Period
- 2024
- Total Assets
- 34.11
- Total Liabilities
- 35.11
- Total Equity
- -1
- Tangible Book Valueper Share Common Eq
- -2.02
- Period
- 2024
- Cashfrom Operating Activities
- 0.97
- Cashfrom Investing Activities
- -3.69
- Cashfrom Financing Activities
- 1.07
- Net Changein Cash
- -1.66
- Period
- 2023
- Total Revenue
- 47.11
- Selling/ General/ Admin Expenses Total
- 3.72
- Depreciation/ Amortization
- 3.27
- Other Operating Expenses Total
- 9.22
- Total Operating Expense
- 46.7
- Operating Income
- 0.41
- Net Income Before Taxes
- -0.79
- Net Income
- -0.79
- Diluted Normalized EPS
- -1.65
- Period
- 2023
- Total Assets
- 34.91
- Total Liabilities
- 35.84
- Total Equity
- -0.93
- Tangible Book Valueper Share Common Eq
- -1.99
- Period
- 2023
- Cashfrom Operating Activities
- 2.23
- Cashfrom Investing Activities
- -0.62
- Cashfrom Financing Activities
- -5.93
- Net Changein Cash
- -4.32
- Period
- 2022
- Total Revenue
- 50.61
- Selling/ General/ Admin Expenses Total
- 3.9
- Depreciation/ Amortization
- 3.09
- Other Operating Expenses Total
- 5.78
- Total Operating Expense
- 42.17
- Operating Income
- 8.44
- Net Income Before Taxes
- 7.63
- Net Income
- 7.63
- Diluted Normalized EPS
- 13.6
- Period
- 2022
- Total Assets
- 39.8
- Total Liabilities
- 39.79
- Total Equity
- 0.02
- Tangible Book Valueper Share Common Eq
- -0.03
- Period
- 2022
- Cashfrom Operating Activities
- 11.6
- Cashfrom Investing Activities
- 0.4
- Cashfrom Financing Activities
- -6.58
- Net Changein Cash
- 5.43
- Period
- 2021
- Total Revenue
- 39.76
- Selling/ General/ Admin Expenses Total
- 3.03
- Depreciation/ Amortization
- 3.28
- Other Operating Expenses Total
- 5.6
- Total Operating Expense
- 36.77
- Operating Income
- 2.99
- Net Income Before Taxes
- -1.1
- Net Income
- -1.1
- Diluted Normalized EPS
- -2.34
- Period
- 2021
- Total Assets
- 35.98
- Total Liabilities
- 31.59
- Total Equity
- 4.39
- Tangible Book Valueper Share Common Eq
- 9.15
- Period
- 2021
- Cashfrom Operating Activities
- 6.53
- Cashfrom Investing Activities
- -0.7
- Cashfrom Financing Activities
- -5.87
- Net Changein Cash
- -0.04
- Period
- 2020
- Total Revenue
- 43.93
- Selling/ General/ Admin Expenses Total
- 3.49
- Depreciation/ Amortization
- 3.41
- Other Operating Expenses Total
- 6.41
- Total Operating Expense
- 40.95
- Operating Income
- 2.98
- Net Income Before Taxes
- -1.55
- Net Income
- -1.57
- Diluted Normalized EPS
- -3.31
- Period
- 2020
- Total Assets
- 38.22
- Total Liabilities
- 44.76
- Total Equity
- -6.54
- Tangible Book Valueper Share Common Eq
- -13.61
- Period
- 2020
- Cashfrom Operating Activities
- 4.83
- Cashfrom Investing Activities
- -0.39
- Cashfrom Financing Activities
- -4.3
- Net Changein Cash
- 0.14
- Period
- 2019
- Total Revenue
- 46.21
- Selling/ General/ Admin Expenses Total
- 3.34
- Depreciation/ Amortization
- 3.53
- Other Operating Expenses Total
- 6.12
- Total Operating Expense
- 38.03
- Operating Income
- 8.18
- Net Income Before Taxes
- 3.57
- Net Income
- 3.56
- Diluted Normalized EPS
- 0.56
- Period
- 2019
- Total Assets
- 39.18
- Total Liabilities
- 44.12
- Total Equity
- -4.94
- Tangible Book Valueper Share Common Eq
- -10.28
- Period
- 2019
- Cashfrom Operating Activities
- 7.85
- Cashfrom Investing Activities
- 3.12
- Cashfrom Financing Activities
- -10.86
- Net Changein Cash
- 0.11
- Period
- 2025-03-31
- Total Revenue
- 8.62
- Selling/ General/ Admin Expenses Total
- 0.83
- Depreciation/ Amortization
- 0.61
- Other Operating Expenses Total
- 3.6
- Total Operating Expense
- 11
- Operating Income
- -2.38
- Net Income Before Taxes
- -2.59
- Net Income
- -2.59
- Diluted Normalized EPS
- -5.16
- Period
- 2025-03-31
- Total Assets
- 31.1
- Total Liabilities
- 39.11
- Total Equity
- -8.01
- Tangible Book Valueper Share Common Eq
- -15.91
- Period
- 2025-03-31
- Cashfrom Operating Activities
- -0.18
- Cashfrom Investing Activities
- -0.21
- Cashfrom Financing Activities
- 0.45
- Net Changein Cash
- 0.07
- Period
- 2024-12-31
- Total Revenue
- 10.78
- Selling/ General/ Admin Expenses Total
- 0.84
- Depreciation/ Amortization
- 0.87
- Other Operating Expenses Total
- 2.28
- Total Operating Expense
- 12.41
- Operating Income
- -1.62
- Net Income Before Taxes
- -1.98
- Net Income
- -1.98
- Diluted Normalized EPS
- -3.92
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 10.61
- Selling/ General/ Admin Expenses Total
- 0.81
- Depreciation/ Amortization
- 0.87
- Other Operating Expenses Total
- 2.05
- Total Operating Expense
- 11.42
- Operating Income
- -0.81
- Net Income Before Taxes
- -1.19
- Net Income
- -1.19
- Diluted Normalized EPS
- -2.35
- Period
- 2024-09-30
- Total Assets
- 32.94
- Total Liabilities
- 36.37
- Total Equity
- -3.43
- Tangible Book Valueper Share Common Eq
- -6.84
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 1.08
- Cashfrom Investing Activities
- -0.29
- Cashfrom Financing Activities
- -0.78
- Net Changein Cash
- 0.01
- Period
- 2024-06-30
- Total Revenue
- 10.57
- Selling/ General/ Admin Expenses Total
- 0.85
- Depreciation/ Amortization
- 0.87
- Other Operating Expenses Total
- 2.35
- Total Operating Expense
- 11.44
- Operating Income
- -0.87
- Net Income Before Taxes
- -1.25
- Net Income
- -1.25
- Diluted Normalized EPS
- -2.47
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 11.02
- Selling/ General/ Admin Expenses Total
- 0.84
- Depreciation/ Amortization
- 0.87
- Other Operating Expenses Total
- 2.63
- Total Operating Expense
- 11.66
- Operating Income
- -0.64
- Net Income Before Taxes
- -0.84
- Net Income
- -0.84
- Diluted Normalized EPS
- -1.46
- Period
- 2024-03-31
- Total Assets
- 34.11
- Total Liabilities
- 35.11
- Total Equity
- -1
- Tangible Book Valueper Share Common Eq
- -2.02
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 0.97
- Cashfrom Investing Activities
- -3.69
- Cashfrom Financing Activities
- 1.07
- Net Changein Cash
- -1.66
- Period
- 2023-12-31
- Total Revenue
- 11.3
- Selling/ General/ Admin Expenses Total
- 0.84
- Depreciation/ Amortization
- 0.83
- Other Operating Expenses Total
- 2.59
- Total Operating Expense
- 12.15
- Operating Income
- -0.84
- Net Income Before Taxes
- -1.21
- Net Income
- -1.21
- Diluted Normalized EPS
- -2.52
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
National Oxygen Technical
Moving Average
SMA
- 5 Day119.45
- 10 Day120.85
- 20 Day117.8
- 50 Day109.14
- 100 Day112.59
- 300 Day122.45
National Oxygen Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Teesta Agro Industries
- 115.5
- 0.6
- 0.52
- 144.16
- 91
- 64.8
- Iel
- 4.71
- 0.01
- 0.21
- 7.1
- 3.36
- 61.54
- National Oxygen
- 111.75
- -2.25
- -1.97
- 165
- 94.95
- 56.35
- The Phosphate Company
- 150.9
- -0.1
- -0.07
- 207.9
- 134.95
- 54.43
- Medi Caps
- 42.5
- -1.27
- -2.9
- 61
- 37.23
- 53
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Teesta Agro Industries
- 9.45
- 0.55
- 5.22
- 2.97
- Iel
- 141.82
- 1.36
- 12.01
- 10.02
- National Oxygen
- -
- -
- -
- -2.01
- The Phosphate Company
- 15.83
- 0.62
- 3.84
- 2.72
- Medi Caps
- -
- 0.45
- 3.59
- 8.86
National Oxygen Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 29-May-25
- Audited Results
- 07-Feb-25
- Quarterly Results
- 11-Nov-24
- Quarterly Results
- 13-Aug-24
- Quarterly Results & A.G.M.
- 22-May-24
- Audited Results
- 02-Mar-24
- Preferential issue of shares
- 13-Feb-24
- Quarterly Results
- 09-Feb-24
- Quarterly Results
- 20-Jan-24
- Preferential issue of shares
- 06-Nov-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 16-Sept-24
- 26-Aug-24
- AGM
- 20-Feb-24
- 29-Jan-24
- EGM
- 28-Aug-23
- 07-Aug-23
- AGM
- 09-Mar-21
- 05-Feb-21
- POM



